Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
antiviral agents
cerebrospinal fluid, elevated protein of
encephalitis
encephalitis, viral
encephalitis, viral-causes of
encephalopathy
immunosuppressive agents
inosiplex
interferon
interferon, intrathecal
interferon, intraventricular
multiple sclerosis
multiple sclerosis, treatment of
Ommaya reservoir
pleocytosis of cerebrospinal fluid
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
treatment of neurologic disorder
viral infection, CNS
Showing articles 150 to 200 of 282 << Previous Next >>

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997

Prognostic Significance of Coexistent Bulky Metastatic CNS Dis in Pts with Leptomeningeal Metastases
Arch Neurol 54:1364-1368, Chamberlain,M.C.&Kormanik,P.A., 1997

Syndrome of Orthostatic Headaches and Diffuse Pachymeningeal Gadolinium Enhancement
Mayo Clin Proc 72:400-413, Mokri,B.,et al, 1997

Massive Nerve Root Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
JNNP 61:636-640, Schady,W.,et al, 1996

Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996

Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996

Acute Spinal Injury
NEJM 334:514-520, Chiles,B.W.&Cooper,P.R., 1996

Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996

Interferon-Alpha is Effective in HTLV-I-Associated Myelopathy:A Multicenter, Randomized, Double-Blind, Controlled Trial
Neurol 46:1016-1021, Izumo,S.,et al, 1996

Progressive Multifocal Leukoencephalopathy:Clinical and MR Response to Treatment
AJNR 17:597-600, Garrels,K.,et al, 1996

Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C
Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996

Intrathecal Baclofen Therapy in Stiff-Man Syndrome:A Double-blind, Placebo-controlled Trial
Neurol 45:1893-1897, Silbert,P.L.,et al, 1995

The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995

New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995

Hepatitis C Infection, Cryoglobulinemia, and Vasculitic Neuropathy. Treatment with Interferon Alfa:Case Rpt & Literat Review
Neurol 45:407-411, Khella,S.L.,et al, 1995

The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995

Myasthenia Gravis During Interferon Alfa Therapy
Neurol 45:382-383, Batocchi,A.P.,et al, 1995

Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995

Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995

Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995

Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1b
NEJM 332:1584, Sheremata,W.A.,et al, 1995

Detection of Cerebrospinal Fluid Metastasis:CT Myelography or MRI?
AJNR 16:1147-1151, Heinz,R.,et al, 1995

Assessment of the Narrow Cervical Spinal Canal:A Prospective Comparison of MRI, Myelography and CT-Myelography
Neuroradiology 37:187-191, Reul,J.,et al, 1995

Surgical Management of Spinal Epidural Hematoma:Relationship Between Surgical Timing and Neurological Outcome
J Neurosurg 83:1-7, Lawton,M.T.,et al, 1995

Interferon-Associated Refractory Status Epilepticus
pediatrics 93:511-512, Miller,V.S.,et al, 1994

Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994

Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994

Sudden Hearing Loss Associated with Interferon
Lancet 343:1134-1135, Kanda,Y.,et al, 1994

Clinical Outcome in Aggressively Treated Meningeal Carcinomatosis
Arch Neurol 51:457-461, Grant,R.,et al, 1994

A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
Arch Neurol 51:1245-1252, Jacobs,L.&Johnson,K.P., 1994

Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994

Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994

Stiff-Man Syndrome Treated with Intrathecal Baclofen
Neurol 43:2412, Penn,R.D.&Mangieri,E.A., 1993

Continuous Intrathecal Baclofen Infusion for Spasticity of Cerebral Origin
JAMA 270:2475-2477, Albright,A.L.,et al, 1993

Treatment of Leptomeningeal Metastasis with Intravent Admin of Depot Cytarabine (DTC 101)
Arch Neurol 50:261-264, Chamberlain,M.C.,et al, 1993

Disk-Caused Nerve Compression in Pts with Acute Low-Back Pain:Diag with MR, CT Myelogr & CT
Radiology 186:731-738, Thornbury,J.R.,et al, 1993

Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993

Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993

Successful Outcome of Progressive Multifocal Leukoencephalopathy with Cytarabine and Interferon
Ann Neurol 33:407-411, Steiger,M.J.,et al, 1993

Bacterial Spinal Epidural Abscess, Review of 43 Cases and Literature Survey
Medicine 71:369-385, Darouiche,R.O.,et al, 1992



Showing articles 150 to 200 of 282 << Previous Next >>